Jane Hollingsworth

Active Investor

Co-Founder & Executive Chair at Eliksa Therapeutics

Philadelphia, Pennsylvania

Jane Hollingsworth, Co-Founder & Executive Chair at Eliksa Therapeutics is an active investor based in Philadelphia, Pennsylvania. This profile covers what Jane Hollingsworth backs, at which stage, and how founders can reach out in 2026.

Investor type: AngelInvestment Partner
Stages: Pre SeedSeedSeries ASeries B
Invests in: Healthcare & BiotechBiotech & PharmaSaaS & EnterpriseIoT & Connected DevicesManufacturing & Industrial
Location: Philadelphia, Pennsylvania
Typical check: $625K
Past investments: 6

Notable investments

University City Science CenterCervoMed, Inc. (NASDAQ: CRVO), formerly Diffusion Pharmaceuticals (NASDAQ: DFFN)Breastcancer.orgThe Kimmel Center for the Performing ArtsRiboNova Inc.Afimmune Ltd

How to reach Jane Hollingsworth

Angels and operators like Jane Hollingsworth reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Jane Hollingsworth invest in?

Jane Hollingsworth invests in Healthcare & Biotech, Biotech & Pharma, SaaS & Enterprise and IoT & Connected Devices, typically at Pre Seed, Seed, Series A and Series B. Match your sector and stage, then reach out with a personalized pitch.

How do I contact Jane Hollingsworth?

Unlock Jane Hollingsworth's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.